Inspire Advisors’s Phibro Animal Health PAHC Stock Holding History

Inspire Advisors’s Portfolio PAHC Stock Details PAHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-4,760	Closed	-$263K	–	787
2026 Q1	$263K	Buy	+4,760	New	+$227K	0.02%	510

Other funds holding PAHC

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Lord, Abbett & Co Jersey City, New Jersey $34.9B AUM 72.7% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Inspire Advisors's PAHC Position: Q2 2026 in Review

Inspire Advisors sold out of Phibro Animal Health (PAHC) in Q2 2026, closing a stake of 4,760 shares — an estimated $263K sold.

Inspire Advisors first reported a position in PAHC in Q1 2026 and held it in 1 quarter. The position peaked at $263K in Q1 2026. 208 funds tracked by Wall St. Rank hold PAHC as of Q2 2026.

Inspire Advisors reported no remaining Phibro Animal Health position as of Q2 2026 after selling out during the quarter.
Inspire Advisors sold 4,760 Phibro Animal Health shares in Q2 2026, an estimated $263K.
Inspire Advisors first reported a position in Phibro Animal Health in Q1 2026 and held it in 1 quarter.
Inspire Advisors's Phibro Animal Health position peaked at $263K in Q1 2026.
208 funds tracked by Wall St. Rank held Phibro Animal Health as of Q2 2026.

Based on Inspire Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.